137 related articles for article (PubMed ID: 8935748)
1. Successful treatment on an out-patient basis of a patient with Down's syndrome and disseminated testicular seminoma.
Sleijfer S; Koops HS; van der Graaf WT
Neth J Med; 1996 Mar; 48(3):89-91. PubMed ID: 8935748
[TBL] [Abstract][Full Text] [Related]
2. Down's syndrome associated with seminoma in undescended testis.
Ichiyanagi O; Sasagawa I; Kubota Y; Yaguchi H; Suzuki Y; Nakada T
Scand J Urol Nephrol; 1998 Sep; 32(5):365-7. PubMed ID: 9825403
[TBL] [Abstract][Full Text] [Related]
3. Seminoma associated with bilateral cryptorchidism in Down's syndrome: a case report.
Miki M; Ohtake N; Hasumi M; Ohi M; Moriyama S
Int J Urol; 1999 Jul; 6(7):377-80. PubMed ID: 10445309
[TBL] [Abstract][Full Text] [Related]
4. [A case of Down's syndrome associated with recurrent testicular tumor treated by chemotherapy successfully: review of 41 cases in Japanese literature].
Yoneda S; Nakazawa S; Takezawa K; Kato T; Tanigawa G; Fujita K; Okumi M; Hosomi M; Fushimi H; Yamaguchi S
Hinyokika Kiyo; 2010 Jul; 56(7):397-401. PubMed ID: 20724816
[TBL] [Abstract][Full Text] [Related]
5. Carboplatin and cyclophosphamide in the treatment of metastatic seminoma.
Mardiak J; Sálek T; Sycova-Milá Z; Sufliarsky J; Baláz M; Koza I
Neoplasma; 2000; 47(4):244-7. PubMed ID: 11043830
[TBL] [Abstract][Full Text] [Related]
6. Challenges in treating patients with Down's syndrome and testicular cancer with chemotherapy and radiotherapy: The Royal Marsden experience.
Hafeez S; Sharma RA; Huddart RA; Dearnaley DP; Horwich A
Clin Oncol (R Coll Radiol); 2007 Mar; 19(2):135-42. PubMed ID: 17355110
[TBL] [Abstract][Full Text] [Related]
7. Treatment of advanced seminoma with cyclophosphamide, vincristine and carboplatin on an outpatient basis.
Sleijfer S; Willemse PH; de Vries EG; van der Graaf WT; Schraffordt Koops H; Mulder NH
Br J Cancer; 1996 Sep; 74(6):947-50. PubMed ID: 8826863
[TBL] [Abstract][Full Text] [Related]
8. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours.
Fizazi K; Prow DM; Do KA; Wang X; Finn L; Kim J; Daliani D; Papandreou CN; Tu SM; Millikan RE; Pagliaro LC; Logothetis CJ; Amato RJ
Br J Cancer; 2002 May; 86(10):1555-60. PubMed ID: 12085204
[TBL] [Abstract][Full Text] [Related]
9. Treatment experiences of testicular cancer in Hispanic patients with Down's syndrome at the National Cancer Institute of Mexico.
Aguilar-Ponce JL; Vidal-Millán S; Molina-Calzada C; Chilaca-Rosas F; Martínez-Cedillo J; Cruz-López JC
Clin Transl Oncol; 2008 Nov; 10(11):768-71. PubMed ID: 19015076
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of metastatic seminoma by chemotherapy.: an experience].
Komatsubara S; Itoi T; Watanabe M; Kitamura Y; Koike T
Nihon Hinyokika Gakkai Zasshi; 2000; 91(10-11):666-72. PubMed ID: 11109817
[TBL] [Abstract][Full Text] [Related]
11. [A case of Down's syndrome associated with testicular seminoma].
Ashizawa Y; Maruyama A; Shibuya M; Hariu K; Tanaka W; Tohyama Y; Yotsukura M; Satoh S; Shimizu H; Tomomasa H; Iizumi T; Umeda T
Hinyokika Kiyo; 2000 Apr; 46(4):287-9. PubMed ID: 10845165
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of stage-IIIB seminoma with single-agent carboplatin therapy.
Bohle W; Ruether U; Rassweiler J; Nunnensiek C; Eisenberger F; Jipp P
Urol Int; 1997; 59(1):53-4. PubMed ID: 9313327
[TBL] [Abstract][Full Text] [Related]
13. Cyclophosphamide and carboplatin and selective consolidation in advanced seminoma.
Amato RJ; Millikan R; Daliani D; Wood L; Logothetis C; Pollack A
Clin Cancer Res; 2000 Jan; 6(1):72-7. PubMed ID: 10656434
[TBL] [Abstract][Full Text] [Related]
14. Association of Down's syndrome and testicular cancer.
Dieckmann KP; Rübe C; Henke RP
J Urol; 1997 May; 157(5):1701-4. PubMed ID: 9112509
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin, vincristine and ifosphamide combination chemotherapy of metastatic seminoma: results of EORTC trial 30874. EORTC GU Group.
Fosså SD; Droz JP; Stoter G; Kaye SB; Vermeylen K; Sylvester R
Br J Cancer; 1995 Mar; 71(3):619-24. PubMed ID: 7880748
[TBL] [Abstract][Full Text] [Related]
16. Myths and facts on adjuvant carboplatin for stage I seminoma.
Aparicio J; Germà JR
J Clin Oncol; 2006 Jul; 24(21):e40. PubMed ID: 16849740
[No Abstract] [Full Text] [Related]
17. A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party.
Horwich A; Oliver RT; Wilkinson PM; Mead GM; Harland SJ; Cullen MH; Roberts JT; Fossa SD; Dearnaley DP; Lallemand E; Stenning SP;
Br J Cancer; 2000 Dec; 83(12):1623-9. PubMed ID: 11104556
[TBL] [Abstract][Full Text] [Related]
18. Testicular seminoma and Down's syndrome.
Roberge D; Souhami L; Laplante M
Can J Urol; 2001 Feb; 8(1):1203-6. PubMed ID: 11268309
[TBL] [Abstract][Full Text] [Related]
19. An excess of testicular germ cell tumors in Down's syndrome: three case reports and a review of the literature.
Satgé D; Sasco AJ; Curé H; Leduc B; Sommelet D; Vekemans MJ
Cancer; 1997 Sep; 80(5):929-35. PubMed ID: 9307193
[TBL] [Abstract][Full Text] [Related]
20. Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials.
Bokemeyer C; Kollmannsberger C; Stenning S; Hartmann JT; Horwich A; Clemm C; Gerl A; Meisner C; Rückerl CP; Schmoll HJ; Kanz L; Oliver T
Br J Cancer; 2004 Aug; 91(4):683-7. PubMed ID: 15266338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
